The purpose of the Institutional Biosafety Committee (IBC) at Marquette University is to review research with recombinant DNA (rDNA) being conducted at Marquette. Institutions that receive support from the National Institutes of Health (NIH) for rDNA research are required to establish and register an Institutional Biosafety Committee (IBC) with the NIH Office of Biotechnology Activities (OBA) in compliance with the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
The Marquette University IBC committee is responsible for the oversight, administration, and review of all MU projects involving research with rDNA that may pose safety, health, or environmental risks. The IBC will assist and advise Principal Investigators, and other researchers in meeting their responsibilities to ensure that the biological aspects of the research are conducted in a safe manner using Marquette University established biosafety standards and principles. The Office of Environmental Health and Safety and Office of Research Compliance also are included to make sure that safe research includes worker safety, public health, environmental protection, ethics, and compliance with applicable biosafety and university standards